EPS Phase 4

EPS Phase 4

Roll-out of Electronic Prescription Service (EPS) Phase 4 to GP practices enables those GP practices to use electronic prescribing even for those patients that do not have EPS nomination. This helps the move towards greater percentage of EPS dispensing.

Roll-out from November 2019

From 18th November EPS Phase 4 began rolling out to more GP practices using the TPP SystmOne GP system. All community pharmacy teams should therefore be aware that they may receive EPS Phase 4 tokens to process. Full rollout for TPP SystmOne GP system practices will take place in the coming weeks and months on a location by location basis. Areas going live this year include parts of London, Gloucestershire and Greater Huddersfield. Rollout dates for EMIS, Microtest and Vision GP practices will be finalised later. Specific dates will be made available on NHS Digital’s EPS Phase 4 deployment schedule webpage.

The start of the national rollout follows a successful pilot which tested the functionality in all four GP prescribing systems. The pilot began in November 2018 and involved 60 GP practices across England.

Under EPS Phase 4, patients can choose to take their token to any pharmacy in England. If you receive a Phase 4 token, simply scan the barcode and dispense it as you would any other electronic prescription. As with all EPS prescriptions, dispense notifications and endorsements need to be added to the electronic prescription using your pharmacy system. Endorsements written or printed onto any type of EPS token will not be processed by the NHS Business Services Authority (NHSBSA).

Recommended actions

Refresh your EPS Phase 4 knowledge with PSNC’s top tips for processing Phase 4 prescriptions and learn more on this phase 4 webpage below:

What is Phase 4?

Previously, it was only possible to issue an EPS prescription where the patient nominated a pharmacy or another dispenser. EPS had been most advantageous for patients who received regular medication and who tended to get their prescriptions dispensed at the same pharmacy most of the time.

Under Phase 4 of EPS, prescriptions would be sent via EPS by default, whether a patient has an EPS nomination in place or not. However, where certain criteria are met, a paper prescription would still be used, for example:

  • when a patient explicitly asks their GP for a paper prescription; or
  • when the medicine being prescribed is not listed in the NHS list of medicines (dm+d).

However, many of the benefits associated with EPS are associated with nomination, therefore as EPS progresses with more GP practices being ‘Phase 4’ ready, it is important that appropriate patients continue to be given the opportunity to benefit from using nomination. All existing nominations will remain valid and further nominations for appropriate patients should continue to be set.

What happens if a patient has not set a nomination?

A patient who has not set a nomination or does not wish to do so would be issued with an EPS Phase 4 green prescription token so that they may visit the pharmacy of their choice. Pharmacy teams would scan the bar code on the token to access the EPS script.

The token will be provided in a paper format, but in time tokens may be available in an electronic format (e.g. in an email from the GP practice, via a website or via an app). This approach would generally mean the prescription cannot be prepared before the patient presents in the pharmacy.

Preparations made in association with Phase 4

NHS Digital identified several opportunities to progress EPS matters leading up to and during the Phase 4 wider rollouts:

  • the EPS service model was reviewed and the highest priority recommendations were implemented;
  • pharmacy training events (PMR system-specific) were held across the country; and
  • EPS Controlled Drugs (CDs) (Schedule 2 and 3) was widely rolled out across almost every GP practice.

PSNC continues to work with NHS England and NHS Digital to address issues with EPS which are detailed in PSNC’s EPS log. Community Pharmacy IT Group (CP ITG) also feed into the log. 

The Phase 4 pilot

NHS Digital piloted EPS Phase 4 from late 2018 at around 60 GP practices. A successful outcome was reached.

Phase 4 top tips for pharmacy teams

Recommended tips:

  • If you receive a Phase 4 token, you should scan the barcode and dispense it as you would any other electronic prescription.
  • Pharmacy teams can use the green Phase 4 prescription tokens to capture any patient exemption-related or charge-related signatures.
  • Green Phase 4 tokens should be filed with all the other white EPS tokens and not within the main bundle of paper prescriptions before the submission is sent to the NHSBSA.
  • Consider your system and print settings. Many PMR systems have settings to customise which types of EPS prescriptions may automatically have a white EPS dispensing token printed.
  • Some pharmacy teams that process the Phase 4 token used a highlighter pen or a sticker to highlight the ‘Prescriber signature not required’ wording on the token, to highlight that it is a Phase 4 token rather than a barcoded paper prescription.
  • During the earlier stages of the rollout, patients have sometimes filled in the back of the green Phase 4 token before they arrived at the pharmacy. If the pharmacy process involves shredding the green Phase 4 token and replacing it with a newly printed white dispensing token, the patient will have to complete the reverse of the dispensing token. To address this scenario, some pharmacy teams have changed their initial Phase 4 approach so that they use the green Phase 4 token for patient declarations, rather than printing out a new white EPS dispensing token for each Phase 4 script.

Phase 4 materials for GP practice staff

Should pharmacy teams receive a question from GP practice colleagues about what EPS Phase 4 is, then pharmacy teams may choose to highlight that there are some materials on the NHS Digital website:

The Phase 4 deployment plan involves a plan so that GP practice staff within GP practices that are about to go live with Phase 4, should be made aware about EPS Phase 4.

How to report any Phase 4 technical issues which require reporting?

If you have an EPS Phase 4 issue that requires reporting, you can use the usual escalation routes to do this. In addition you may email PSNC’s Community Pharmacy IT Lead, Daniel Ah-Thion.

Frequently asked questions

Q. Can EPS Tracker be used to view information relating to a Phase 4 prescription ?

Yes, EPS Phase 4 prescriptions can be identified using the EPS Tracker search (by prescription reference or by patient NHS number). EPS Phase 4 prescriptions will not be included within the ‘my prescriptions’ area until after your pharmacy has downloaded the EPS Phase 4 prescription into your PMR system.

Return to the IT section: EPS home

Return to the IT webpage: Future pharmacy IT developments

Return to the Pharmacy IT hub page

 



Latest Dispensing and Supply news

View more Dispensing and Supply news >

Metformin Safety Update

The Medicines and Healthcare products Regulatory Agency (MHRA) has been made aware that outside of the UK very low amounts...